Serendex Pharmaceuticals' IPO

Serendex Pharmaceuticals raised a round of funding on June 06, 2014. Investors include Public.

Serendex Pharmaceuticals is a pharmaceutical development company, specializing in inhalation therapies for the treatment of patients with severe pulmonary conditions.…

Articles about Serendex Pharmaceuticals' IPO: